NASDAQ:CURX | Free Cash Flow | Curanex Pharmaceuticals Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$954,560.00
2025-12-31-$857,404.00
2025-03-31-$149,948.00
2024-12-31-$95,427.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.48M
2024-12-31-$555,575.00